Internal Medicine
Online ISSN : 1349-7235
Print ISSN : 0918-2918
ISSN-L : 0918-2918
49 巻, 14 号
選択された号の論文の33件中1~33を表示しています
EDITORIAL
ORIGINAL ARTICLES
  • Nobuyuki Miyatake, Kenichi Shikata, Hirofumi Makino, Takeyuki Numata
    2010 年 49 巻 14 号 p. 1315-1320
    発行日: 2010年
    公開日: 2010/07/15
    ジャーナル オープンアクセス
    Objective We investigated the link between renal function as evaluated by estimated glomerular filtration rate (eGFR) and pulse wave velocity (PWV) in Japanese without medications.
    Methods A total of 1,244 Japanese subjects, aged 20-79 years, were recruited in a cross-sectional clinical investigation study. They received no medications. eGFR was calculated using serum creatinine (Cr), age and sex. Peripheral arterial stiffness was evaluated by brachial-ankle PWV (baPWV).
    Results eGFR and baPWV were significantly correlated with age. eGFR was negatively correlated with baPWV (men: r=-0.308, p<0.0001, women: r=-0.293, p<0.0001). Twenty-six men (5.6%) and 35 women (4.5%) were diagnosed as reduced eGFR (eGFR <60 mL/min/1.73 m2). We compared clinical parameters between subjects with reduced eGFR (Group R) and without such reduction (Group N). baPWV in Group R was significantly higher than that in Group N even after adjusting for age. In women, systolic blood pressure in Group R was also significantly higher than that in Group N.
    Conclusion eGFR was closely associated with peripheral arterial stiffness in Japanese.
  • Hideaki Yamabe, Norio Nakamura, Michiko Shimada, Reiichi Murakami, Tak ...
    2010 年 49 巻 14 号 p. 1321-1323
    発行日: 2010年
    公開日: 2010/07/15
    ジャーナル オープンアクセス
    Purpose Patients with hepatitis C virus (HCV)-associated glomerulonephritis in whom HCV RNA was not detected in the blood have been reported. We attempted to uncover the differences between HCV RNA-negative and HCV RNA-positive cases.
    Methods The clinical and pathological findings for 5 patients with HCV-associated glomerulonephritis without HCV in the blood were compared with those for 23 patients with HCV RNA-positive HCV-associated glomerulonephritis.
    Results The HCV RNA-negative cases were characterized by advanced age, female dominance, no cryoglobulinemia and no glomerular deposition of IgG compared with the HCV RNA-positive cases, although no differences were observed in amount of urinary protein, frequency of nephrotic syndrome, serum levels of total protein, creatinine level, presence of hypocomplementemia and rheumatoid factor. The prognosis was similar for both groups.
    Conclusion These cases point to the need for further study of the pathogenesis of this disease.
  • Ming-Lung Chuang, Chih-Hsin Lee, I-Feng Lin
    2010 年 49 巻 14 号 p. 1325-1332
    発行日: 2010年
    公開日: 2010/07/15
    ジャーナル オープンアクセス
    Background Maximal incremental exercise testing should be completed within 8-12 minutes. The ramp-slope influences the exercise duration. Oxygen-cost diagram (OCD) is a scoring scale for the capability of daily activity performed and therefore can be used to estimate the ramp-slope.
    Methods The OCD-algorithm and the reported-algorithm were used prospectively in random order for selecting optimal ramp-slope: Ramp-slopeOCD=ScoreOCD×weight in kg/40 for men and weight/50 for women and Ramp-slopereported=(Predicted VO2peak-VO2unloaded)/100. Fifty-three dyspneic patients and 16 normal controls were enrolled to perform a ramp-pattern exercise. Fourteen patients not reaching maximum exercise levels were excluded. The exercise capacity, exercise time, and success rate of loaded exercise between 8 and 12 minutes were measured.
    Results Comparing the reported-algorithm to the OCD-algorithm in normal controls, the only difference was that the ramp-slope was higher in males; in patients, the ramp-slope was higher in males, the exercise time shorter and the success rate lower (8.6±3.3 vs. 9.4±2.1 min, 61.5% vs. 84.6%, both p<0.05); in obese patients, the ramp-slope was lower and the exercise time longer.
    Conclusion OCD score can predict the ramp-slope selection for exercise testing in normal controls and dyspneic patients. This may be affected by gender and body weight when using the reported-algorithm for dyspneic patients.
  • Yasutsugu Fukushima, Fumiya Fukushima, Kuniyoshi Kamiya, Yumeko Hayash ...
    2010 年 49 巻 14 号 p. 1333-1340
    発行日: 2010年
    公開日: 2010/07/15
    ジャーナル オープンアクセス
    Objective To examine the relation between annual trends in the antimicrobial susceptibility of Pseudomonas aeruginosa and drug usage, we compared annual changes in the susceptibility rates of P. aeruginosa clinical isolates during a 4-year period and annual trends in the overall usage of antimicrobials during the same period.
    Methods We studied annual trends in MIC90/MIC50, antimicrobial use density (AUD), and antimicrobial susceptibility rates based on clinical breakpoints for 150 strains of P. aeruginosa isolated from respiratory specimens at Dokkyo Medical University Hospital from 2005 through 2008.
    Results The MIC90/MIC50 of antimicrobials effective against P. aeruginosa in years 2005, 2006, 2007, and 2008 were as follows: imipenem, 32/2, 32/1, 8/2, and 16/1 μg/mL; meropenem, 8/1, 8/1, 4/0.5, and 4/0.5 μg/mL; and biapenem, 16/1, 32/0.5, 4/0.5, and 8/0.5 μg/mL, indicating that susceptibility to carbapenems increased slightly. The MIC90/MIC50 was 4/0.25, 2/0.125, 1/0.125, and 2/0.25 μg/mL for ciprofloxacin, 8/4, 8/4, 4/4, and 8/4 μg/mL for amikacin, 64/16, 64/16, 64/16, and 64/16 μg/mL for sulbactam/cefoperazone, 8/2, 16/2, 32/2, and 8/2 μg/mL for ceftazidime, indicating little change. The AUDs of fourth-generation cephalosporins increased from 2005 to 2008 (16.2, 18.4, 28.0, and 23.0), while the AUDs of carbapenems decreased (25.7, 23.7, 10.9, and 12.5).
    Conclusion The decrease in the AUDs of carbapenems was associated with increased susceptibility rates of P. aeruginosa to carbapenem derivatives. A continuous understanding of trends in the resistance of P. aeruginosa and various other pathogens is essential for designing countermeasures against nosocomial infections, including the proper and effective use of antimicrobials.
  • Keisuke Tomii, Ryo Tachikawa, Kazuo Chin, Kimihiko Murase, Tomohiro Ha ...
    2010 年 49 巻 14 号 p. 1341-1347
    発行日: 2010年
    公開日: 2010/07/15
    ジャーナル オープンアクセス
    Introduction Invasive mechanical ventilation (IMV) is not effective for acute exacerbation of interstitial pneumonia (AE-IP); however, the role of non-invasive ventilation (NIV) for this condition remains unknown.
    Methods Comparisons were made for two periods: before (October 2001 - September 2003) and after (October 2004 - September 2006) the introduction of NIV as the primary method of mechanical ventilation for AE-IP. We retrospectively screened emergent admissions and enrolled consecutively those patients with AE-IP who had acutely worsening hypoxemia with new infiltrates, background chronic interstitial CT changes, and no findings suggestive of other diseases. The two periods were compared primarily for 60-day survival and secondarily for other outcomes associated with mechanical ventilation.
    Results Medical records were retrieved for 11 episodes in 11 patients identified from 485 pre-NIV records and 27 episodes in 22 patients from 859 post-NIV records. Five patients required IMV in the earlier cohort and 9 patients received NIV in the later cohort. Although there was no difference in the PaO2/FiO2 ratio on admission (167 vs. 139), the 60-day survival rate for all episodes in the later cohort was better than in the earlier cohort (27% vs. 65%, p=0.02). Moreover, the NIV-administered group had a better 60-day survival rate (0% vs. 44%, p=0.03), shorter high-care unit stay (17 vs. 6 days, p=0.03) and better-preserved verbal communication (0 vs., 89%) than the IMV-administered group.
    Conclusion Use of NIV in place of IMV for the management of life-threatening AE-IP appears to result in a better 60-day survival rate, lower high-care unit use and better patient tolerability.
  • Xiao Li, Feng Xu, Qi He, Lingyun Wu, Zheng Zhang, Chunkang Chang
    2010 年 49 巻 14 号 p. 1349-1355
    発行日: 2010年
    公開日: 2010/07/15
    ジャーナル オープンアクセス
    Objective The subsets and the polarization of lymphocytes in bone marrow from low-risk myelodysplastic syndrome (MDS) were studied and compared with those from patients with aplastic anemia (AA).
    Methods A total of 34 patients with low-risk MDS (IPSS score≤1.0) who presented abnormal chromosomes and 16 patients with AA were enrolled in this study. We determined T lymphocyte subsets, T cells polarization status, and the percentages of NK cells and of B lymphocytes in bone marrow and compared these parameters between the two groups of patients. As controls, 24 patients with high-risk MDS (IPSS score>1.0) presenting abnormal chromosomes and 22 healthy/benign hematologic disease subjects were used.
    Results In low-risk MDS/AA patients, the percentage of CD3+ lymphocytes was significantly increased compared to controls (p=0.006 and p=0.001), while the percentage of CD19+ lymphocytes was significantly decreased (p<0.001 and p=0.002); there were no significant differences between MDS/AA and normal controls in other parameters; For low-risk MDS patients, the polarization status of bone marrow CD4+ cells toward Th1 (Th1/Th2) and of CD8+ cells toward Tc1 (Tc1/Tc2) was stronger than that for AA patients (p=0.05 and p<0.001). Other parameters did not show significant differences; Regardless of the predominance of CD4 or CD8 T cells, all patients with low-risk MDS were accompanied with elevated Tc1 polarization (Tc1/Tc2).
    Conclusion In both AA and MDS, the number of total T lymphocytes increased. However, polarization towards Th1 and Tc1 was obviously stronger in MDS patients than in AA patients. This might be related to T cell stimulation from the clones of malignant hematopoietic cells.
  • Tsuyoshi Matsumura, Takuhisa Tamura, Satoshi Kuru, Yasuki Kikuchi, Mit ...
    2010 年 49 巻 14 号 p. 1357-1363
    発行日: 2010年
    公開日: 2010/07/15
    ジャーナル オープンアクセス
    Objective Heart failure is one of the most serious complications in Duchenne muscular dystrophy (DMD). Beta-blocker medication is known to improve the prognosis of chronic heart failure of adults, but its efficacy and safety for DMD patients has not been fully assessed. Thus we conducted a multicenter open trial.
    Methods Fifty-four DMD patients participated; 41 received carvedilol (BB group) and 13 did not (non BB group). All patients with an ejection fraction of less than 50% received angiotensin-converting enzyme inhibitor. Then, patients in BB group were started on carvedilol. The mean maintenance dose of carvedilol in BB group was 7.85±2.80 mg/day. Clinical signs and cardiac function were monitored regularly and statistical analysis was done.
    Results The survival rate free from primary endpoints (death, deterioration of heart failure and severe arrhythmia) was higher in the BB group. The survival rate free from all-cause death was also higher in the BB group, although not significantly higher. Patients with primary endpoints received lower maintenance doses of carvedilol and presented higher mean heart rates (HR) during the observation period. In the BB group, mean HR at enrollment and the reduction of mean HR were correlated with the change of ejection fraction. Although serious adverse events were rare during the introduction of carvedilol, patients with advanced cardiac dysfunction required a longer period for up-titration and frequently presented with minor complaints.
    Conclusion The present study suggests that carvedilol is relatively safe and can prevent cardiac events even in patients with DMD.
  • Motohisa Yamamoto, Hiroki Takahashi, Chisako Suzuki, Tetsuya Tabeya, M ...
    2010 年 49 巻 14 号 p. 1365-1370
    発行日: 2010年
    公開日: 2010/07/15
    ジャーナル オープンアクセス
    Objective Mikulicz's disease (MD) is characterized by symmetrical and persistent enlargement of the lacrimal and salivary glands. Recently it has been categorized as an 'Ig (immunoglobulin) G4-related disease.' It presents with elevated serum levels of IgG4 and abundant infiltration of IgG4-bearing plasmacytes in involved organs. Allergic symptoms are often observed in patients with IgG4-related disease. On the other hand, allergic diseases are often complicated with Churg-Strauss syndrome (CSS). Here we focused on CSS and analyzed the relation of IgG4 in its pathogenesis.
    Materials and Methods We analyzed five patients (2 men and 3 women) with CSS and 51 patients (20 men and 31 women) with MD who presented at Sapporo Medical University Hospital since 2001. We measured the serum concentrations of IgG subclasses in the patients with MD and CSS, and evaluated renal specimens from CSS patients, staining them for anti-IgG4 antibody.
    Results We surprisingly found elevated serum levels of IgG4 not only in MD but also in CSS patients. The renal specimens in CSS patients revealed the infiltration of IgG4-positive plasmacytes.
    Conclusion IgG4-bearing plasmacytes may be involved in the pathogenesis of CSS, and it is possible that an allergic reaction plays an important role in the pathogenesis of IgG4-related disease.
CASE REPORTS
PICTURES IN CLINICAL MEDICINES
LETTERS TO THE EDITORS
feedback
Top